index - Epidemiology in dermatology and evaluation of therapeutics Accéder directement au contenu

DOCUMENTS

Chargement de la page

 

NOTICES

Chargement de la page

 

 

MOTS CLES

Graft-versus-host disease Amyloidosis Biological Therapy Adalimumab Accelerometer Ustekinumab Management Autoimmunity Auto-immune hepatitis Ethics COVID-19 Pregnancy Sacroiliitis Antimicrobial Stewardship Atopic dermatitis Biological therapy Apremilast Antibiotic resistance Quality of life Anti-TNF CSK tyrosine-protein kinase Biologics Prostate cancer Infliximab Biologic Abus d'antibiotiques Anxiety Cardiomyopathy Bacterial Immune checkpoint inhibitors Albinism Psoriasis Psoriatic arthritis Placebo Primary adrenal insufficiency Vigibase® ArtThese ASDAS Pharmacovigilance Sipuleucel-T Anti-Bacterial Agents Axial spondyloarthritis BTK protein Azathioprine Angiotensin-converting enzyme inhibitors Endocrine toxicity Spondyloarthritis Biomarkers Treatment Biologic drug Antimicrobial resistance Addiction Pharmacoepidemiology Biomédicaments Adolescent Atrial fibrillation Antimicrobiens Meta-Analysis Antibiotic misuse Epidemiology Stability Pharmaco-Épidémiologie Aging Cardio-oncology Antibiotics Antimicrobials Immune-related adverse events Autoimmune diseases Angiotensin receptor blockers Adverse side effects Dermatology Arrhythmia Alcohol Ankylosing spondylitis Ankylosing Arthritis Acute Myeloid Leukaemia AML Anti-HCV Direct Acting Antivirals DAA Cancer Burden Etanercept Alitretinoin Drug reaction CTLA-4 Glucocorticoids Bacterial rhinosinusitis Anticancer drugs Anxiété Méta-Analyse Apre-milast Intensive care Spondylitis Cardiotoxicity Beta-lactam antibiotics Access to care Drug survival Immunotherapy Biologic therapy Auto-Diagnostic Biosimilar Pharmaceuticals

 

 

 

Epidemiology in Dermatology and Evaluation of therapeutics , EA 7379

Adresse

Université Paris-Est Créteil Val de Marne (UPEC)

Campus Centre de Créteil
61 Avenue du Général de Gaulle
94010 Créteil Cedex

Courriel

emilie.sbidian@aphp.fr

Site Internet

 

Rattachement(s)

UFR de Santé

Direction

Émilie SBIDIAN

 

Axe(s) de recherche

 


[legende-image]65[/legende-image] Axe 1 : Comment mieux gérer les patients ayant développé des réactins graves aux médicaments, notamment en leur indiquant comment utiliser correctement les agents


[legende-image]65[/legende-image] Axe 2 : Rechercher les facteurs associés aux effets indesirables et à l'efficacité du médicament

 
 

COLLABORATIONS